NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Advaxis Inc (NASDAQ: ADXS)

 
ADXS Technical Analysis
5
As on 28th Apr 2025 ADXS STOCK Price closed @ 0.10 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.80 & Strong Sell for SHORT-TERM with Stoploss of 1.03 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ADXSSTOCK Price

Open 0.03 Change Price %
High 0.10 1 Day 0.07 233.33
Low 0.03 1 Week 0.07 233.33
Close 0.10 1 Month 0.04 66.67
Volume 30005 1 Year -0.87 -89.69
52 Week High 1.38 | 52 Week Low 0.00
 
NASDAQ USA Most Active Stocks
AGMH 0.13 160.00%
AMRS 0.14 100.00%
DGLY 0.03 0.00%
GNLN 0.01 0.00%
PTPI 0.06 20.00%
PLUG 1.02 25.93%
NVDA 108.73 -2.05%
TSLA 285.88 0.33%
WW 0.41 2.50%
LMDX 0.02 0.00%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
XFOR 5.34 2710.53%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
ADXS 0.10 233.33%
NDRAW 0.03 200.00%
AGMH 0.13 160.00%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
TFFP 0.06 -62.50%
ATMH 0.04 -60.00%
MILEW 0.06 -53.85%
VINC 0.05 -50.00%
 
 
ADXS
Daily Charts
ADXS
Intraday Charts
Whats New @
Bazaartrend
ADXS
Free Analysis
 
ADXS Important Levels Intraday
RESISTANCE0.23
RESISTANCE0.19
RESISTANCE0.16
RESISTANCE0.14
SUPPORT0.06
SUPPORT0.04
SUPPORT0.01
SUPPORT-0.03
 
ADXS Forecast April 2025
4th UP Forecast0.99
3rd UP Forecast0.7
2nd UP Forecast0.53
1st UP Forecast0.35
1st DOWN Forecast-0.15
2nd DOWN Forecast-0.33
3rd DOWN Forecast-0.5
4th DOWN Forecast-0.79
 
ADXS Weekly Forecast
4th UP Forecast1.35
3rd UP Forecast0.95
2nd UP Forecast0.70
1st UP Forecast0.45
1st DOWN Forecast-0.25
2nd DOWN Forecast-0.50
3rd DOWN Forecast-0.75
4th DOWN Forecast-1.15
 
ADXS Forecast2025
4th UP Forecast3.86
3rd UP Forecast2.65
2nd UP Forecast1.91
1st UP Forecast1.16
1st DOWN Forecast-0.96
2nd DOWN Forecast-1.71
3rd DOWN Forecast-2.45
4th DOWN Forecast-3.66
 
 
ADXS Other Details
Segment EQ
Market Capital 70517920.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ADXS Address
ADXS
 
ADXS Latest News
 
Your Comments and Response on Advaxis Inc
 
ADXS Business Profile
Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for the treatment of prostate cancer. It is also conducting clinical studies of Lm Technology immunotherapies in the following areas of disease focused hotspot/off-the-shelf neoantigen-directed therapies; human papilloma virus-associated cancers; and prostate cancer. The company has collaborations and partnerships with Merck & Co., Inc.; OS Therapies, LLC; Aratana Therapeutics Inc.; Biocon Limited; Global BioPharma Inc.; Knight Therapeutics Inc; and others. Advaxis, Inc. was founded in 2002 and is based in Monmouth Junction, New Jersey. Address: 9 Deer Park Drive, Monmouth Junction, NJ, United States, 08852
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service